Comment: Bezos’, Musk’s fight shows errors of U.S. space policy

In trimming costs, then placating loser, Congress spends more and gets far less for lunar landers.

By Adam Minter / Bloomberg Opinion

Last week, the Senate passed a measure that would allot $10 billion over five years for NASA to develop two new lunar landers.

Buried in a nearly $250 billion bill intended to boost innovation, the measure was equal to about 43 percent of the space agency’s total budget. Why the extravagance? On one level, it surely makes sense to build a backup lander if astronauts are going to return to the moon in 2024 as planned. But there may also have been a less reputable motive.

In April, a group led by Jeff Bezos’s Blue Origin lost out on a competitive bid to build the lander to Elon Musk’s SpaceX. Bezos loudly protested. Now, rather than leaving the fight to the plutocrats, Congress might expand the pool of money; and potentially make both men winners. That would be a mistake.

The fact is, Congress screwed up the bidding process for this project the first time around, and its fix is likely to lead to delays and added costs, not to mention (understandable) complaints about a billionaire bailout. The incident neatly sums up what’s wrong with the way Congress funds and directs space policy.

For decades, the biggest barrier between Americans and outer space hasn’t been technology, engineering or courage. It’s been money. Just months after Neil Armstrong first walked on the moon, NASA began canceling some of its future landings. Yet even as budgets tightened, ambitions remained steady to a fault. In 2003, the board tasked with investigating the Space Shuttle Columbia disaster noted that NASA had become “an organization straining to do too much with too little.”

One way to fix that problem is to boost its budget. The problem is that lawmakers tend to spend too much on things NASA doesn’t need, while shortchanging things it does. In 2011, Congress ordered the agency to develop the Space Launch System, a giant rocket based on antiquated technology, at Alabama’s Marshall Space Flight Center (a major employer that Sen. Richard Shelby, R-Alabama, is adept at keeping flush with funds). The result has been an overbudget and overdue rocket that still hasn’t flown.

Another approach is for NASA to become a customer. In the mid-2000s, the agency began offering competitive grants for companies to launch cargo to the International Space Station. It was a success: In return for a relatively modest $800 million, SpaceX and Orbital Sciences (now part of Northrop Grumman) developed two new rockets and two new cargo spacecraft. A few years later, a similar program produced SpaceX’s Dragon craft, which last year successfully ferried two astronauts to the space station. If not for persistent budget shortfalls, that launch likely would’ve taken place much earlier.

Those successes inspired NASA to hold a competition to develop landers for a proposed trip to the moon. Last year, the agency chose SpaceX, Dynetics (a unit of Leidos Holdings) and a team of traditional space contractors led by Blue Origin as competitors. Initially, NASA envisioned selecting two teams to build landers. But while the agency requested $3.3 billion for the program in 2021, Congress authorized just $850 million. As a result, NASA chose only one proposal: SpaceX’s.

Blue Origin and Dynetics both filed protests, and NASA suspended the program pending the outcome. Some of the companies’ suppliers argued that a single lander was a threat not just to safety but to jobs and the broader economy. Sen. Maria Cantwel, D-Wash, Blue Origin’s home state, took notice. Shortly after SpaceX’s win, she introduced an amendment that would require NASA to pick a second winner within 30 days of enactment, and authorize $10 billion over five years for the project.

That would be enough to pay for both proposals. But the bill is moving the goalposts on NASA and the bidders to the detriment of both. Had Congress initially offered that sum, both companies almost certainly would’ve proposed something different. Now Blue Origin gets more money for a design that NASA judged inferior and too expensive. NASA gets two landers that aren’t as good as they could’ve been. And the lunar-landing program will likely face more delays and higher costs. Meanwhile, Cantwell’s colleagues are already challenging the provision; shortly after it passed committee, Sen. Bernie Sanders, I-Vt., offered an amendment to “eliminate the multi-billion dollar Bezos Bailout.”

Such tension and uncertainty could’ve been avoided had lawmakers simply appropriated enough money to fulfill their mandates in the first place. But spats like this help explain why America’s crewed space program has been struggling to get off the ground again.

Adam Minter is a Bloomberg Opinion columnist. He is the author of “Junkyard Planet: Travels in the Billion-Dollar Trash Trade” and “Secondhand: Travels in the New Global Garage Sale.”

Talk to us

More in Opinion

Abel Villafan, center, looks on as his wife Maria, right, gets the second shot of the Pfizer COVID-19 vaccine from Cecilia Valdovinos, left, Thursday, March 25, 2021, at the Yakima Valley Farm Workers Clinic in Toppenish, Wash. Villafan, who drives tractors and other machinery at Roy Farms, a hops and fruit producer in Moxee, Wash., also got his second shot Thursday. In Washington state, seasonal workers who are beginning to arrive to join year-round employees to work on hops farms and in cherry and apple orchards became eligible for the vaccine earlier in the month. (AP Photo/Ted S. Warren)
Editorial: What’s it going to take to get more vaccinated?

The vaccines are safe, effective and our best hope to keep kids in schools, learning and healthy.

toon
Editorial cartoons for Thursday, Aug. 5

A sketchy look at the news of the day.… Continue reading

FILE - In this May 21, 2021 file photo, a person holds a mask while walking outside in Philadelphia.  New evidence showing the delta variant is as contagious as chickenpox has prompted U.S. health officials to consider changing advice on how the nation fights the coronavirus. Recommending masks for everyone and requiring vaccines for doctors and other health care providers are among measures the Centers for Disease Control and Prevention is considering, Friday, July 30. (AP Photo/Matt Rourke, File)
Editorial: Our covid battle isn’t over; we must again mask up

The delta variant spreads even among whose who are vaccinated, meaning a return to masking indoors.

Comment: Fed up, businesses, employers are mandating vaccines

Frustrated by a lack of government mandates, businesses and employers are setting their own rules.

Comment: Trump, tax lawyers wrong about Congress’ oversight

A judge could rule soon on the release of Trump’s tax returns to Congress; and the American people.

Comment: Gender, race, politics gets an independent news site

The 19th started during a year of monumental change and used that change to focus its coverage.

Vaccine hesitancy came before Trump

Regarding Washington Post columnist Kathleen Parker July 26 column on Capitol rioters… Continue reading

Olympics focused too much on nationalism

I’m sick of the Olympics. They’ve become a war between nations who… Continue reading

toon
Editorial cartoons for Wednesday, Aug. 4

A sketchy look at the news of the day.… Continue reading

Most Read